Elanco Animal Health, Inc.

48
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US28414H1032
USD
21.99
-0.19 (-0.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Elanco Animal Health, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
488.00
-1,195.00
-72.00
-571.00
-672.00
78.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
149.00
-300.00
-462.00
-88.00
165.00
-227.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
541.00
271.00
452.00
483.00
-41.00
224.00
Cash Flow from Investing Activities
1,158.00
-169.00
-179.00
-530.00
-4,779.00
-234.00
Cash Flow from Financing Activities
-1,492.00
-83.00
-549.00
210.00
4,953.00
-304.00
Net Cash Inflow / Outflow
116.00
7.00
-293.00
132.00
160.00
-332.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-91.00
-12.00
-17.00
-31.00
26.00
-16.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Elanco Animal Health, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
488
185.689
303.00
162.81%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
149
-10.106
159.00
1574.37%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
541
298.981
243.00
80.95%
Cash Flow from Investing Activities
1158
-203.03
1,361.00
670.36%
Cash Flow from Financing Activities
-1492
-122.398
-1,370.00
-1118.97%
Net Cash Inflow / Outflow
116
-28.78
144.00
503.06%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-91
-2.333
-89.00
-3800.56%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 99.63% vs -40.04% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
541.00
271.00
99.63%